Increased ATP production during long-term brain ischemia in rats in the presence of propentofylline
- PMID: 9669493
- DOI: 10.1016/s0014-2999(98)00172-1
Increased ATP production during long-term brain ischemia in rats in the presence of propentofylline
Abstract
Forty adult rats were subjected to stepwise two- and four-brain vessel occlusion and propentofylline 25 mg/day per kilogram body weight was intraperitoneally administered for 1 week or 3 weeks. Adenosine 5'-triphosphate, creatine phosphate, adenosine 5'-diphosphate and adenosine were determined in rat parietotemporal cortex by high-pressure liquid chromatography; lactate and pyruvate were measured spectrophotometrically. Stepwise and permanent long-term brain vessel occlusion gradually reduced the concentration of energy-rich phosphates and induced a marked increase in the concentration of adenosine, a parameter of ischemia. Three weeks of propentofylline treatment resulted in a significant increase in cerebral adenosine 5'-triphosphate concentration from 2.16 +/- 0.15 [(-)-propentofylline] to 2.70 +/- 0.24 nmol/mg wet weight during four-vessel occlusion (+25%). This was associated with an enhancement of the adenosine 5'-triphosphate/adenosine 5'-diphosphate ratio (+33%), mainly because of the significant reduction in adenosine 5'-diphosphate concentration. Propentofylline did not prevent the increase in lactate concentration during permanent brain vessel occlusion, but significantly reduced the tissue concentration of adenosine. In summary, the results demonstrate that continuous propentofylline administration over 3 weeks induced a striking increase in rat cortical adenosine 5'-triphosphate concentration during long-term brain vessel occlusion. Thus, propentofylline may have possible neuroprotective effects and could be used in the treatment of patients with chronic cerebrovascular disorders.
Similar articles
-
Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.Br J Pharmacol. 2001 May;133(1):107-16. doi: 10.1038/sj.bjp.0704061. Br J Pharmacol. 2001. PMID: 11325800 Free PMC article.
-
Effect of propentofylline on hippocampal brain energy state and amyloid precursor protein concentration in a rat model of cerebral hypoperfusion.J Neural Transm (Vienna). 1998;105(8-9):1065-77. doi: 10.1007/s007020050112. J Neural Transm (Vienna). 1998. PMID: 9869336
-
Effect of propentofylline on cerebral blood flow in a gerbil focal cerebral ischemia.J Neurol Sci. 2001 Jan 15;183(1):57-60. doi: 10.1016/s0022-510x(00)00477-9. J Neurol Sci. 2001. PMID: 11166795
-
Propentofylline: a nucleoside transport inhibitor with neuroprotective effects in cerebral ischemia.Gen Pharmacol. 1994 Oct;25(6):1053-8. doi: 10.1016/0306-3623(94)90119-8. Gen Pharmacol. 1994. PMID: 7875526 Review.
-
Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain.Handb Exp Pharmacol. 2011;(200):235-50. doi: 10.1007/978-3-642-13443-2_8. Handb Exp Pharmacol. 2011. PMID: 20859798 Review.
Cited by
-
Plasticity of purine release during cerebral ischemia: clinical implications?J Cell Mol Med. 2003 Oct-Dec;7(4):362-75. doi: 10.1111/j.1582-4934.2003.tb00239.x. J Cell Mol Med. 2003. PMID: 14754505 Free PMC article. Review.
-
Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy.J Exp Stroke Transl Med. 2010 Mar 15;3(1):47-55. doi: 10.6030/1939-067x-3.1.47. J Exp Stroke Transl Med. 2010. PMID: 20607107 Free PMC article.
-
Neuromodulatory effect of propentofylline on rat brain under acute and long-term hypoperfusion.Br J Pharmacol. 2001 May;133(1):107-16. doi: 10.1038/sj.bjp.0704061. Br J Pharmacol. 2001. PMID: 11325800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources